Circulating chemerin level is independently correlated with arterial stiffness

Hye-Jin Yoo, Hae Yoon Choi, Sae Jeong Yang, Hee Young Kim, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Dong Seop Choi, Sei-Hyun Baik

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Aim: Adipokines have been implicated in the pathogenesis of obesity and obesity-related disorders, including atherosclerosis. Chemerin is a recently discovered adipokine which is closely correlated with various metabolic phenotypes in humans. We examined the association between circulating chemerin levels and arterial stiffness, as represented by the brachial ankle pulse wave velocity (baPWV). Methods: Fifty-eight obese and 62 non-obese individuals participated in the study. We measured the serum chemerin and high sensitivity C-reactive protein (hsCRP) levels, and the homeostasis model assessment of insulin resistance (HOMA-IR), as well as other cardiovascular risk factors. Vascular health was assessed by the baPWV and carotid intima-media thickness (IMT). Results: The serum chemerin level was significantly increased in obese individuals compared with lean controls (120.14±19.43 ng/mL vs. 106.81±23.39 ng/mL, p = 0.001). The circulating chemerin level had a significant positive correlation with the body mass index, waist circumference, HOMA-IR, and low-density lipoprotein-cholesterol, triglycerides, and hsCRP levels. The serum chemerin level was significantly associated with the baPWV (r = 0.280, p = 0.002), but not the carotid IMT (r = 0.065, p = 0.504). Multiple stepwise regression analysis showed that age (p < 0.001), waist circumference (p = 0.038), systolic blood pressure (p < 0.001), and serum fasting glucose (p = 0.003) and chemerin levels (p = 0.017) were definitive risk factors for arterial stiffness (r 2 = 0.457). Conclusions: The circulating chemerin level was an independent risk factor for arterial stiffness even after adjusting for other cardiovascular risk factors.

Original languageEnglish
Pages (from-to)59-68
Number of pages10
JournalJournal of Atherosclerosis and Thrombosis
Volume19
Issue number1
DOIs
Publication statusPublished - 2012 Feb 9

Fingerprint

Vascular Stiffness
Pulse Wave Analysis
Stiffness
Ankle
Carotid Intima-Media Thickness
Adipokines
Arm
Waist Circumference
Serum
C-Reactive Protein
Insulin Resistance
Homeostasis
Obesity
Insulin
Blood Pressure
Blood pressure
Regression analysis
LDL Cholesterol
Blood Vessels
Fasting

Keywords

  • Atherosclerosis
  • Chemerin
  • Pulse wave velocity

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine
  • Biochemistry, medical

Cite this

Circulating chemerin level is independently correlated with arterial stiffness. / Yoo, Hye-Jin; Choi, Hae Yoon; Yang, Sae Jeong; Kim, Hee Young; Seo, Ji A; Kim, Sin Gon; Kim, Nan Hee; Choi, Kyung Mook; Choi, Dong Seop; Baik, Sei-Hyun.

In: Journal of Atherosclerosis and Thrombosis, Vol. 19, No. 1, 09.02.2012, p. 59-68.

Research output: Contribution to journalArticle

@article{413a5f1027bd4de083e22afaf0c20226,
title = "Circulating chemerin level is independently correlated with arterial stiffness",
abstract = "Aim: Adipokines have been implicated in the pathogenesis of obesity and obesity-related disorders, including atherosclerosis. Chemerin is a recently discovered adipokine which is closely correlated with various metabolic phenotypes in humans. We examined the association between circulating chemerin levels and arterial stiffness, as represented by the brachial ankle pulse wave velocity (baPWV). Methods: Fifty-eight obese and 62 non-obese individuals participated in the study. We measured the serum chemerin and high sensitivity C-reactive protein (hsCRP) levels, and the homeostasis model assessment of insulin resistance (HOMA-IR), as well as other cardiovascular risk factors. Vascular health was assessed by the baPWV and carotid intima-media thickness (IMT). Results: The serum chemerin level was significantly increased in obese individuals compared with lean controls (120.14±19.43 ng/mL vs. 106.81±23.39 ng/mL, p = 0.001). The circulating chemerin level had a significant positive correlation with the body mass index, waist circumference, HOMA-IR, and low-density lipoprotein-cholesterol, triglycerides, and hsCRP levels. The serum chemerin level was significantly associated with the baPWV (r = 0.280, p = 0.002), but not the carotid IMT (r = 0.065, p = 0.504). Multiple stepwise regression analysis showed that age (p < 0.001), waist circumference (p = 0.038), systolic blood pressure (p < 0.001), and serum fasting glucose (p = 0.003) and chemerin levels (p = 0.017) were definitive risk factors for arterial stiffness (r 2 = 0.457). Conclusions: The circulating chemerin level was an independent risk factor for arterial stiffness even after adjusting for other cardiovascular risk factors.",
keywords = "Atherosclerosis, Chemerin, Pulse wave velocity",
author = "Hye-Jin Yoo and Choi, {Hae Yoon} and Yang, {Sae Jeong} and Kim, {Hee Young} and Seo, {Ji A} and Kim, {Sin Gon} and Kim, {Nan Hee} and Choi, {Kyung Mook} and Choi, {Dong Seop} and Sei-Hyun Baik",
year = "2012",
month = "2",
day = "9",
doi = "10.5551/jat.9647",
language = "English",
volume = "19",
pages = "59--68",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "1",

}

TY - JOUR

T1 - Circulating chemerin level is independently correlated with arterial stiffness

AU - Yoo, Hye-Jin

AU - Choi, Hae Yoon

AU - Yang, Sae Jeong

AU - Kim, Hee Young

AU - Seo, Ji A

AU - Kim, Sin Gon

AU - Kim, Nan Hee

AU - Choi, Kyung Mook

AU - Choi, Dong Seop

AU - Baik, Sei-Hyun

PY - 2012/2/9

Y1 - 2012/2/9

N2 - Aim: Adipokines have been implicated in the pathogenesis of obesity and obesity-related disorders, including atherosclerosis. Chemerin is a recently discovered adipokine which is closely correlated with various metabolic phenotypes in humans. We examined the association between circulating chemerin levels and arterial stiffness, as represented by the brachial ankle pulse wave velocity (baPWV). Methods: Fifty-eight obese and 62 non-obese individuals participated in the study. We measured the serum chemerin and high sensitivity C-reactive protein (hsCRP) levels, and the homeostasis model assessment of insulin resistance (HOMA-IR), as well as other cardiovascular risk factors. Vascular health was assessed by the baPWV and carotid intima-media thickness (IMT). Results: The serum chemerin level was significantly increased in obese individuals compared with lean controls (120.14±19.43 ng/mL vs. 106.81±23.39 ng/mL, p = 0.001). The circulating chemerin level had a significant positive correlation with the body mass index, waist circumference, HOMA-IR, and low-density lipoprotein-cholesterol, triglycerides, and hsCRP levels. The serum chemerin level was significantly associated with the baPWV (r = 0.280, p = 0.002), but not the carotid IMT (r = 0.065, p = 0.504). Multiple stepwise regression analysis showed that age (p < 0.001), waist circumference (p = 0.038), systolic blood pressure (p < 0.001), and serum fasting glucose (p = 0.003) and chemerin levels (p = 0.017) were definitive risk factors for arterial stiffness (r 2 = 0.457). Conclusions: The circulating chemerin level was an independent risk factor for arterial stiffness even after adjusting for other cardiovascular risk factors.

AB - Aim: Adipokines have been implicated in the pathogenesis of obesity and obesity-related disorders, including atherosclerosis. Chemerin is a recently discovered adipokine which is closely correlated with various metabolic phenotypes in humans. We examined the association between circulating chemerin levels and arterial stiffness, as represented by the brachial ankle pulse wave velocity (baPWV). Methods: Fifty-eight obese and 62 non-obese individuals participated in the study. We measured the serum chemerin and high sensitivity C-reactive protein (hsCRP) levels, and the homeostasis model assessment of insulin resistance (HOMA-IR), as well as other cardiovascular risk factors. Vascular health was assessed by the baPWV and carotid intima-media thickness (IMT). Results: The serum chemerin level was significantly increased in obese individuals compared with lean controls (120.14±19.43 ng/mL vs. 106.81±23.39 ng/mL, p = 0.001). The circulating chemerin level had a significant positive correlation with the body mass index, waist circumference, HOMA-IR, and low-density lipoprotein-cholesterol, triglycerides, and hsCRP levels. The serum chemerin level was significantly associated with the baPWV (r = 0.280, p = 0.002), but not the carotid IMT (r = 0.065, p = 0.504). Multiple stepwise regression analysis showed that age (p < 0.001), waist circumference (p = 0.038), systolic blood pressure (p < 0.001), and serum fasting glucose (p = 0.003) and chemerin levels (p = 0.017) were definitive risk factors for arterial stiffness (r 2 = 0.457). Conclusions: The circulating chemerin level was an independent risk factor for arterial stiffness even after adjusting for other cardiovascular risk factors.

KW - Atherosclerosis

KW - Chemerin

KW - Pulse wave velocity

UR - http://www.scopus.com/inward/record.url?scp=84863011607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863011607&partnerID=8YFLogxK

U2 - 10.5551/jat.9647

DO - 10.5551/jat.9647

M3 - Article

C2 - 22104178

AN - SCOPUS:84863011607

VL - 19

SP - 59

EP - 68

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 1

ER -